Stay Informed

Sign up for news & alerts

Already signed up?
Login here
What Can I Do?


Get Help
Need alcohol or drug help for yourself or someone else? GET HELP
Resources
Resources
Find useful publications, online documents & more.


DrugScreening.org


 

Nicotine Hinders Chemotherapy, Study Finds
April 3, 2006

Email
Email
Print
Print
SubscribeSubscribe
Research Summary

Continuing to use nicotine patches or gums after cancer surgery -- to say nothing of smoking -- makes chemotherapy less effective, according to researchers at the University of South Florida.

The Associated Press reported April 2 that a study of lung-cancer patients found that nicotine appears to protect cancer cells from chemotherapy drugs like gemcitabine, cisplatin, and taxol. Srikumar Chellappan of the University of South Florida and colleagues studied the impact of nicotine on non-small cell lung cancer, the most common form of the disease.

"Our findings are in agreement with clinical studies showing that patients who continue to smoke have worse survival profiles than those who quit before treatment," the study noted. "They also raise the possibility that nicotine supplementation for smoking cessation might reduce the response to chemotheraputic agents."

The research appears in the online edition of Proceedings of the National Academy of Sciences.

COMMENTS ON THIS ARTICLE:

Your Turn! Post a public comment (guidelines):

Name:

Comment:
(limit 200
words)

Enter this word: Change

GUIDELINES:

  1. Keep it clean, courteous, non-commercial, and on-topic.

  2. Please do not post personal requests for help or personal contact information (Click here for help resources).

  3. Proof your comments carefully. They are published immediately and cannot be edited by you or by us.

  4. Making your post readable with careful spelling and punctuation will strengthen your point.  Don't use ALL CAPS.

We reserve the right to remove comments that do not conform to these guidelines (Report an inappropriate comment).

Have questions or feedback? Contact us.